Effects of Olmesartan Medoxomil, an Angiotensin II Type 1 Receptor Antagonist, on Plasma Concentration of B-Type Natriuretic Peptide, in Hypertensive Patients with Type 2 Diabetes Mellitus: A Preliminary, Observational, Open-Label Study

By Kawai Toshihide   Takei Izumi   Shimada Akira  

Clinical Drug Investigation, Vol. 31, Iss. 4, 2011-04 ,pp. : 237-245

Adis International

Access to resources Recommend Favorite

Effect on the Atherogenic Marker Plasminogen Activator Inhibitor Type-1 of Addition of the ACE Inhibitor Imidapril to Angiotensin II Type 1 Receptor Antagonist Therapy in Hypertensive Patients with Abnormal Glucose Metabolism: A Prospective Cohort Study in Primary Care

By Yajima Ken   Shimada Akira  

Clinical Drug Investigation, Vol. 29, Iss. 12, 2009-12 ,pp. : 811-819

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of Long-Acting Nifedipine GITS/OROS Monotherapy or Combination Therapy in Hypertensive Patients: Results of a 12-Week International, Prospective, Multicentre, Observational Study

By Ueng Kwo-Chang  

Clinical Drug Investigation, Vol. 31, Iss. 9, 2011-09 ,pp. : 631-642

Adis International

Access to resources Recommend Favorite

Which Strategy Is More Effective for the Treatment of Cardiovascular Disease: High-Dose Angiotensin II Type 1 Receptor Antagonist Monotherapy or Combination Therapy?

By Miura Shin-ichiro   Saku Keijiro  

American Journal of Cardiovascular Drugs, Vol. 8, Iss. 2, 2008-01 ,pp. : 88-90

Adis International

Access to resources Recommend Favorite

Relationship between Plasma B-type Natriuretic Peptide and Ventricular Function in Adult Cardiac Surgery Patients

By Jeong DS   Kim K-H   Kim CY   Kim JS  

The Journal of International Medical Research, Vol. 36, Iss. 1, 2008-01 ,pp. : 31-39

Field House Publishing

Access to resources Recommend Favorite